Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Letrozole and LGD-4033 Interaction: Avoid | Peptide Database

Compound Profiles Letrozole Aromatase Inhibitor | Potent Estrogen Suppression Letrozole competitively and reversibly binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), inhibiting its catalytic activity with greater potency than any other c

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Letrozole

Aromatase Inhibitor | Potent Estrogen Suppression

Letrozole competitively and reversibly binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), inhibiting its catalytic activity with greater potency than any other commercially available aromatase inhibitor. Aromatase catalyzes the final step in estrogen biosynthesis, converting testosterone to estradiol and androstenedione to estrone in peripheral tissues including adipose, muscle, liver, and brain.

LGD-4033

Selective Androgen Receptor Modulator | Lean Mass

LGD-4033 binds to the androgen receptor with high affinity (Ki of approximately 1 nM), functioning as a potent and selective agonist in muscle and bone tissue. Like other SARMs, its tissue selectivity is mediated by differential cofactor recruitment: upon binding to the AR, LGD-4033 induces a receptor conformation that preferentially recruits coactivators expressed in skeletal muscle and bone, while showing minimal agonist activity in androgen-sensitive tissues such as the prostate and skin.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Letrozole with LGD-4033?

Combining Letrozole with LGD-4033 is not recommended. Both Letrozole and LGD-4033 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Letrozole and LGD-4033 safe together?

This combination carries significant risk. Both Letrozole and LGD-4033 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Letrozole and LGD-4033?

Both Letrozole and LGD-4033 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 64% confidence and is inferred from pharmacological mechanism analysis.

How should I time Letrozole and LGD-4033?

Letrozole has a half-life of ~2 days (48 hours) and LGD-4033 has a half-life of ~24-36 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Community Research

Join others researching Teriparatide — share findings, ask questions, and learn from real experiences Teriparatide is an FDA-approved anabolic bone-building agent consisting of the first 34 amino acids of parathyroid hormone. Unlike antiresorptive osteoporosis drugs that slow bone loss, teriparatide actively stimulates new bone formation. The key to its mechanism is intermittent exposure: while continuous PTH causes bone resorption, daily injections stimulate osteoblasts more than osteoclasts, resulting in net bone formation. Clinical trials show 8% spine bone density increases and 65% reduction in vertebral fractures. Teriparatide binds to PTH type 1 receptors (G-protein coupled receptors) on osteoblasts, osteocytes, and renal tubular cells. This activates PKA and PKC signaling pathways that promote osteoblast activity. The intermittent daily dosing creates an 'anabolic window' where bone formation exceeds resorption. Teriparatide upregulates IGF-1 and FGF2 expression, stimulates bone formation on trabecular and cortical surfaces, and increases bone mineral density through preferential osteoblast stimulation.

Source: peptide-db.com ↗

Research Indications

Superdrol produces substantial lean mass gains in compressed timeframes, typically 8-12 pounds of lean tissue in a 3-4 week cycle. These gains are notably dry and devoid of water retention due to the absence of estrogenic activity. Widely reported to produce some of the most dramatic strength increases of any oral steroid. Users commonly report significant personal records within the first 2-3 weeks of use. As a non-aromatizing DHT derivative, Superdrol promotes a dense, dry, and grainy muscular appearance without subcutaneous water retention. Often used in the final weeks before a bodybuilding competition.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Tadalafil is exclusively administered orally as film-coated tablets. It can be taken with or without food, as high-fat meals do not significantly affect absorption rate or extent. Two distinct dosing strategies exist: as-needed dosing for planned sexual activity, and daily low-dose for continuous coverage and BPH management. As-needed ED (starting dose) 10mg As needed, at least 30 min before sexual activity Oral As-needed ED (adjusted dose) 20mg As needed, max once per 24 hours Daily low-dose ED (initiation) 2.5mg Once daily, same time each day Daily low-dose ED (standard) 5mg BPH / LUTS Once daily Combined ED and BPH Performance / Pre-workout (conservative) 12.5mg Twice per week (e.g., training days) Performance / Pre-workout (standard) Every other day (EOD) Performance / Pre-workout (aggressive) Pulmonary arterial hypertension (Adcirca) 40mg

Source: peptide-db.com ↗
Side effects

Common Side Effects

Hepatic stress with elevated liver enzymes (ALT, AST) -- moderate severity, dose- and duration-dependent HDL cholesterol suppression (significant, often 30-50% reduction) LDL cholesterol elevation Suppression of endogenous testosterone production via HPG axis negative feedback Mild gastrointestinal discomfort or nausea Back pumps (lower back tightness during exercise, common with 17-alpha-alkylated compounds) Oily skin and mild acne Decreased appetite in some users

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides